Information Provided By:
Fly News Breaks for September 5, 2018
MYGN, HOLX, PKI
Sep 5, 2018 | 07:01 EDT
Barclays analyst Jack Meehan upgraded PerkinElmer (PKI) to Equal Weight from Underweight and raised his price target for the shares to $90 from $79. The analyst is more positive on PerkinElmer's near-term growth prospects in Diagnostics due to its recent investments. Combined with margin expansion and capital deployment, he thinks PerkinElmer is better positioned to drive low-to-mid teens earnings growth. Meehan this morning also downgraded Hologic (HOLX) to Equal Weight and Myriad Genetics (MYGN) to Underweight.
News For PKI;HOLX;MYGN From the Last 2 Days
There are no results for your query PKI;HOLX;MYGN